ArticleJournal of cardiothoracic surgery2026
Mid-term outcomes after totally video guided thoracoscopic mitral valve surgery.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTotally video-guided thoracoscopic surgery (TVTS) has emerged as a minimally invasive alternative to conventional surgery with full sternotomy for mitral valve surgery. Evaluation of clinical outcomes of TVTS mitral valve surgery is essential for guiding patient selection and surgical planning.
methodsWe conducted a retrospective study of 368 consecutive patients who underwent TVTS for mitral valve repair at a tertiary academic center to evaluate the safety and efficacy of this minimally invasive approach.
resultsMitral valve repair was accomplished using the respect technique in 96.4% %, using two PTFE artificial-cordae on the posterior leaflet in 61.7% of patients. In-hospital mortality was 0.8%, stroke 1.2% and ECMO support was required for 1.4% of patients. The median follow-up was 2.5 years (q1; q3 1.18;4.15) and it was complete in 98.6% of patients. At 5-year, all-cause mortality was 3.0% and the rate of major cardiac and cerebrovascular events and reoperations were respectively 1.9% and 1.7%.
conclusionsProvided adequate surgical expertise, TVTS mitral valve surgery can be performed with good early and mid-clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.